Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 10:14 am Purchase |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
CVI Investments, Inc. | 200,000 6.200% |
200,000 (New Position) |
Filing History |
| 2025-04-09 5:31 pm Unchanged |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-04-08 8:00 pm Purchase |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
BIGGER CAPITAL FUND L P | 200,000 6.200% |
200,000 (New Position) |
Filing History |
| 2025-04-07 4:51 pm Purchase |
2025-04-02 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 200,000 6.210% |
200,000 (New Position) |
Filing History |
| 2025-02-10 6:58 pm Unchanged |
2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 76,598 4.990% |
0 (Unchanged) |
Filing History |
| 2025-02-10 4:24 pm Purchase |
2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 76,598 4.990% |
76,598 (New Position) |
Filing History |
| 2024-11-14 3:45 pm Purchase |
2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO |
Armistice Capital, LLC | 22,128 4.990% |
22,128 (New Position) |
Filing History |
| 2024-11-08 2:57 pm Purchase |
2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 25,285 6.960% |
25,285 (New Position) |
Filing History |
| 2024-02-14 3:24 pm Purchase |
2023-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Armistice Capital, LLC | 1,063 9.990% |
1,063 (New Position) |
Filing History |
| 2023-02-14 10:15 am Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 0 0.000% |
-177 (Position Closed) |
Filing History |
| 2022-02-10 3:18 pm Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Renaissance Technologies LLC | 42 1.400% |
-114 (-73.00%) |
Filing History |
| 2021-11-26 1:00 pm Sale |
2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-566 (Position Closed) |
Filing History |
| 2021-11-22 5:28 pm Sale |
2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 566 18.800% |
-515 (-47.65%) |
Filing History |
| 2021-06-21 09:00 am Unchanged |
2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 39.600% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:13 pm Sale |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Point72 Asset Management, L.P. | 0 0.000% |
-178 (Position Closed) |
Filing History |
| 2021-02-16 2:51 pm Unchanged |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Armistice Capital, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 4:56 pm Purchase |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Stonepine Capital Management, LLC | 11 0.400% |
11 (New Position) |
Filing History |
| 2021-02-12 09:25 am Sale |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 177 6.960% |
-1 (-0.61%) |
Filing History |
| 2021-02-10 9:17 pm Purchase |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Renaissance Technologies LLC | 156 5.810% |
156 (New Position) |
Filing History |
| 2021-02-09 08:30 am Unchanged |
2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 40.200% |
0 (Unchanged) |
Filing History |